🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

20 results for “decitabine” Clear

  1. Decitabine

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  2. Decitabine

    First Tracks Biotherapeutics

    Thrombocytopenia

    phase 3 small molecule completed

    1 trial

  3. Decitabine

    China SXT Pharmaceuticals

    Myelodysplastic Syndrome

    phase 3 small molecule completed

    1 trial

  4. Decitabine

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia, Adult

    phase 3 small molecule active

    1 trial

  5. Decitabine plus HAAG regimen

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  6. GLASDEGIB , DAUNORUBICIN , AZACITIDINE , AMSACRINE , CYTARABINE , DECITABINE , FLUDARABINE , ETOPOSIDE , GILTERITINIB, IDARUBICIN , VENETOCLAX , MITOXANTRONE , IVOSIDENIB , CYTARABINE , CLADRIBINE , GEMTUZUMAB OZOGAMICIN

    Istituto Gentili S.r.l.

    Acute myeloid leukemia

    phase 3 small molecule active

    1 trial

  7. decitabine

    First Tracks Biotherapeutics

    Acute Myelocytic Leukemia

    phase 3 small molecule active

    1 trial

  8. decitabine

    First Tracks Biotherapeutics

    Poor Graft Function

    phase 3 small molecule active

    1 trial

  9. Decitabine

    China SXT Pharmaceuticals

    AML

    phase 2 small molecule terminated

    1 trial

  10. Decitabine

    Teva Pharma GmbH

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  11. Decitabine

    CATALYST PHARMACEUTICALS, INC.

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  12. Decitabine

    Karyopharm Therapeutics

    Ovarian Cancer

    phase 2 small molecule active

    1 trial

  13. Decitabine/Tetrahydrouridine A 5/250 mg, Siklos 1 000 mg film-coated tablet., Placebo (NDec)

    Novo Nordisk A/S

    Sickle cell disease

    phase 2 small molecule active

    1 trial

  14. veneclax, chidaniline combined with azacitidine (VCA) followed by decitabine + MAG regimen (D-MAG)

    First Tracks Biotherapeutics

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  15. ASTX727, ASTX727, Decitabine, ASTX727

    Taiho Pharma Netherlands B.V.

    Myelodysplastic Syndromes (MDS)

    phase 1 small molecule active

    1 trial

  16. Decitabine

    Foghorn Therapeutics

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  17. Guadecitabine

    United Therapeutics Europe Ltd

    Non Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  18. Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Hepatic Impairment

    Taiho Pharma Netherlands B.V.

    Solid tumor, Acute myeloid lymphoma (AML), Myelodysplastic syndrome (MDS)

    phase 1 other active

    1 trial

  19. Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Renal Impairment

    Taiho Pharma Netherlands B.V.

    Acute myeloid lymphoma (AML), myelodysplastic syndrome (MDS), or solid tumors

    phase 1 other active

    1 trial

  20. decitabine

    Karyopharm Therapeutics

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources